- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07944079
Acupuncture Delivery In The Clinical Decision Unit (CDU) For The Management Of Pain, Nausea, And Other Symptoms
The overall goal of this research is to improve the management of distressing symptoms, specifically nausea and pain, in cancer patients within the acute care setting of the CDU at MD Anderson.
Visão geral do estudo
Descrição detalhada
Primary Objectives and Endpoints:
Determine the feasibility of an operational protocol of providing acupuncture treatment for nausea and/or pain in the CDU at MD Anderson Cancer Center. Feasibility will be assessed by the proportion of eligible patients who consent to and receive at least one acupuncture treatment. Successful feasibility will be defined as at least 50% of the eligible patients approached consenting and receiving at least one acupuncture session.
Secondary Objectives and Endpoints:
- Examine changes in pain and nausea reported in cancer patients after a single session of acupuncture in the CDU. Preliminary efficacy will be evaluated by having patients complete the ESAS symptom severity before and after each acupuncture session.
- Examine changes in other symptoms assessed on the ESAS after a single session of acupuncture in the CDU. Individual items will be explored as well as global (all symptoms), physical (drowsiness, nausea, pain, shortness of breath, poor appetite, fatigue), and psychological distress (anxiety and depression) subscales.
- Explore the safety profile of providing acupuncture in the CDU. Data will be collected to systematically document and grade any adverse events related to the acupuncture treatment according to the Common Terminology Criteria for Adverse Events (CTCAE) v6.0.
- Explore the patient experience with acupuncture in the CDU. Patients will be asked about their satisfaction with acupuncture, whether they believe it was helpful to reduce their symptoms, if they would use the service again, and if they would recommend acupuncture to others in the CDU. An additional open-ended question will allow patients to make recommendations for future program or service offerings. Satisfaction will be administered to all study participants after each treatment.
- Explore the CDU staff experience with acupuncture in the CDU. The primary clinician assigned to the patient will be asked about their satisfaction with the use of acupuncture for the patient. They will be asked about the logistics of delivering acupuncture and if they perceive any benefit for the patient from before to after in terms of pain, nausea, or anxiety.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Maxine De La Cruz, MD
- Número de telefone: 713-563-4419
- E-mail: mgde@mdanderson.org
Locais de estudo
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- UT MD Anderson
-
Contato:
- Maxine De La Cruz, MD
- Número de telefone: 713-563-4419
- E-mail: mgde@mdanderson.org
-
Investigador principal:
- Maxine De La Cruz, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Adult patients (aged ≥18 years)
- Presenting with a primary complaint of nausea and/or pain
- ESAS nausea and/or pain score of at least 2
- Admitted to the CDU for observation and management of nausea and/or pain.
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
- History of a bleeding disorder
- Coagulation profile with an INR > 2.0 and/or PTT > 90 seconds
- Initiation of anticoagulation for venous thrombosis within the last 24 hours or not yet at a therapeutic dose
- Evidence of bowel obstruction on imaging
- Platelet count < 25,000/uL
- Absolute Neutrophil Count (ANC) < 1.0 K/uL
- Delirium or cognitive impairment in the opinion of the primary CDU physician that limits the ability to follow instructions or provide informed consent.
- Pregnant patients for whom the treating physician or acupuncturist determines acupuncture is not clinically appropriate.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Treatment with Acupuncture
Participants to recruit from are those participants who are admitted into the CDU at UT MD Anderson. |
Treatment will be administered at the participant's bedside in CDU. Needles will remain in place for 20-25 minutes with each treatment. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Safety and Adverse Events (AEs)
Prazo: Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 6.0 |
Through study completion; an average of 1 year
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Maxine De La Cruz, MD, UT MD Anderson
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026-0644
- NCI-2026-08619 (Outro identificador: NCI-CTRP Clinical Trials Registry)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .